This may be a self-compensatory mechanism of tumor cells supplementing α-ketoglutarate with glutamine [34, 35], aimed at compensating for the reduced ATP production caused by mitochondrial OXPHOS dysfunction caused by knocking down NDUFS3. This evidence concerns the gene NDUFS3 and neoplasm.